Radiation Oncology Market by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), by Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head, and Neck Cancer, Colorectal Cancer, Cervical Cancer, Gynecological Cancer, Others), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Radiation Oncology Market size was valued at USD 6,912.3 million in 2022 and is poised to grow at a significant CAGR of 5.6% over 2023-2029. Radiation oncology, usually referred to as radiation therapy, is a form of cancer treatment in which cancer cells are eradicated using powerful energy beams. By eliminating the genetic material that regulates a cell's growth, it harms the cells. A variety of disciplines are used in the treatment of cancer. The procedure uses high-energy X rays (photons), which are typically delivered using a linear accelerator. The technical progress of radiotherapy equipment, the global rise in cancer incidence, and the rising usage of radiation therapy in oncology treatment are key drivers driving the market. The FDA just authorised Vision RT Ltd.'s DoseRT, an upgraded multi-camera system to monitor both beam and patient placement in real time during radiation, in November 2021. Similarly, in December 2020, the FDA approved Beam Site, a single camera system. Dartmouth and Norris Cotton Cancer Center collaborated on this technology, which collects photos and real-time video of the beam and allows radiation doctors to see therapy delivery in patients. These developments have boosted the radiation oncology business while also enhancing the safety and effectiveness of radiotherapy. Additionally, the radiation oncology industry is experiencing growing demand for radiotherapy as the worldwide cancer burden rises. According to the Globocan 2020 study, around 19.3 million people worldwide were suffering from cancer, with 10.0 million dying as a result. Moreover, the WHO in Europe anticipated that 4.6 million new people were diagnosed with various cancer indications such as prostate, breast, lung, colorectal, and brain in 2020, and that 2.1 million people died from the disease across European nations. According to The American Cancer Society's 2022 report, breast cancer is the most frequent ailment, accounting for around 3.0 lakh and 51,400 new instances of aggressive and non-invasive breast cancers in the United States, respectively.


Radiation Oncology Market Key Developments:
In April 2022, Elekta and GE Healthcare teamed to make precision radiation treatment options more accessible. This would allow the two firms to give hospitals with a full offering of cancer imaging and therapy.

Radiation Oncology Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.6%

Largest Market

Asia Pacific

Fastest Growing Market

North America
Radiation Oncology Market Dynamics

Globally, the number of cancer sufferers is steadily growing. Cancer was the world's second leading cause of death in 2020, accounting for 10 million fatalities, according to the WHO. Each year, cancer kills an estimated 9.6 million people (one out of every six). According to the American Institute for Cancer Research, around 18 million cancer cases were reported worldwide in 2018. As a result, the growing number of cancer patients is propelling the worldwide radiation treatment market.

Key Features of the Reports

  • The radiation oncology market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Radiation Oncology Market Segmentation

By Type
  • External Beam Radiation Therapy
  • Internal Beam Radiation Therapy
By Application
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Gynecological Cancer
  • Others
By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

Breast Cancer sub-segment of the application-wise industry acquired the maximum share of the global radiation oncology Market in 2021.

The market's key players, like Panacea Medical Technologies, have started taking certifications on the latest technologies, making them reliable.

North America will provide more business opportunities for the Global Radiation Oncology Market in the future.

Super specialty hospitals and radiotherapists are the primary customers in the global radiation oncology market.

1. Executive Summary
2. Global Radiation Oncology Market Introduction
2.1. Global Radiation Oncology Market – Taxonomy
2.2. Global Radiation Oncology Market – Definitions
2.2.1. Type
2.2.2. Application
2.2.3. Region
3. Global Radiation Oncology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Radiation Oncology Market Dynamic Factors - Impact Analysis
3.6. Impact of COVID 19 on The Market
3.7. Three Forecast Scenarios - Pessimistic, Conservative and Opportunistic
3.8. Mapping Market Players Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations and Mergers
4. Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Radiation Oncology Market Forecast, By Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
5.1. External Beam Radiation Therapy
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis 
5.2. Internal Beam Radiation Therapy
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Radiation Oncology Market Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.1. Prostate Cancer
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis 
6.2. Breast Cancer
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis 
6.3. Lung Cancer
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Head and Neck Cancer
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Colorectal Cancer
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Cervical Cancer
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Gynecological Cancer
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Other 
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
6.8.4.  
7. Global Radiation Oncology Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Distribution Channel, Distribution Channel, and Region, 2023 - 2029
8. North America Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
8.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.1.1. External Beam Radiation Therapy
8.1.2. Internal Beam Radiation Therapy 
8.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Prostate Cancer
8.2.2. Breast Cancer
8.2.3. Lung Cancer
8.2.4. Head and Neck Cancer
8.2.5. Colorectal Cancer
8.2.6. Cervical Cancer
8.2.7. Gynecological Cancer
8.2.8. Others
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Application and Country, 2023 - 2029
8.5. North America Global Radiation Oncology Market Dynamics – Trends
9. Europe Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
9.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.1.1. External Beam Radiation Therapy
9.1.2. Internal Beam Radiation Therapy 
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Prostate Cancer
9.2.2. Breast Cancer
9.2.3. Lung Cancer
9.2.4. Head and Neck Cancer
9.2.5. Colorectal Cancer
9.2.6. Cervical Cancer
9.2.7. Gynecological Cancer
9.2.8. Others
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Europe Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Application and Country, 2023 - 2029
9.5. Europe Global Radiation Oncology Market Dynamics – Trends
10. Asia-Pacific Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
10.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.1.1. External Beam Radiation Therapy
10.1.2. Internal Beam Radiation Therapy 
10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Prostate Cancer
10.2.2. Breast Cancer
10.2.3. Lung Cancer
10.2.4. Head and Neck Cancer
10.2.5. Colorectal Cancer
10.2.6. Cervical Cancer
10.2.7. Gynecological Cancer
10.2.8. Others
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Rest of Asia-Pacific
10.4. Asia-Pacific Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Application and Country, 2023 - 2029
10.5. Asia-Pacific Global Radiation Oncology Market Dynamics – Trends
11. Latin America Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
11.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.1.1. External Beam Radiation Therapy
11.1.2. Internal Beam Radiation Therapy 
11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Prostate Cancer
11.2.2. Breast Cancer
11.2.3. Lung Cancer
11.2.4. Head and Neck Cancer
11.2.5. Colorectal Cancer
11.2.6. Cervical Cancer
11.2.7. Gynecological Cancer
11.2.8. Others
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Rest of Latin America
11.4. Latin America Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Application and Country, 2023 - 2029
11.5. Latin America Global Radiation Oncology Market Dynamics – Trends
12. Middle East and Africa Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
12.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.1.1. External Beam Radiation Therapy
12.1.2. Internal Beam Radiation Therapy 
12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Prostate Cancer
12.2.2. Breast Cancer
12.2.3. Lung Cancer
12.2.4. Head and Neck Cancer
12.2.5. Colorectal Cancer
12.2.6. Cervical Cancer
12.2.7. Gynecological Cancer
12.2.8. Others
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Saudi Arabia
12.3.2. GCC Countries
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Application and Country, 2023 - 2029
12.5. MEA Global Radiation Oncology Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Type Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Varian Medical Systems, Inc.
13.2.2. Elekta AB
13.2.3. Accuray Incorporated
13.2.4. IBA Radiopharma Solutions
13.2.5. BD (Becton,
  • Varian Medical Systems, Inc.
  • Elekta AB
  • Accuray Incorporated
  • IBA Radiopharma Solutions
  • BD (Becton, Dickinson and Company)
  • Isoray Inc.
  • Mevion Medical Systems
  • Nordion, Inc.
  • NTP Radioisotopes SOC Ltd.
  • Curium
  • View Ray Technologies, Inc.

Adjacent Markets